In this episode, dermatologist Joel Gelfand, MD, and rheumatologist Alexis Ogdie, MD, provide deeper insight into the overlap and transition of care between patients with psoriasis and PsA.
Karen Onel, MD, Nayimisha Balmuri, MD, and Jacob Spitznagle, MD, speak with us about the ethics of sex/gender assessment in a pediatric rheumatology population.
In this episode, Michael George, MD, talks to us about ArthritisPower, Jeff Greenberg, MD, discusses the work of CorEvitas, and Christie Bartels, MD, provides further insight into the ACR’s RISE Registry.
This episode features Nehad Soloman, MD, who discusses the implications of the fictional depictions of gout in film and television and how providers can address this.
Peter Grayson, MD, of the NIH tells us the story behind the discovery of the new inflammatory syndrome, VEXAS, and the importance of research at a molecular level in rheumatology.
In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.
In this episode, we get further insight into the current state of biosimilars development and adoption in the United States vs other countries, interchangeability among adult and pediatric patients with rheumatologic conditions, nonmedical switching to biosimilars, and an overview of its potential cost benefits for the US healthcare system.
In this episode, we highlight and address the disproportionate burden of rheumatic diseases and COVID-19 in ethnic minorities and the gender disparities observed in rheumatology care.
In part 2 of this series, we’re getting perspectives from an allopathic and an osteopathic physician specializing in rheumatology on the evolution of telemedicine and what the future may look like for the management of rheumatologic conditions.
Telemedicine in rheumatology, or telerheumatology, may be the future of diagnosis and treatment in rheumatology. In this 2-part episode series, we’re delving deeper into the world of telerheumatology and asking, “Will this be the new normal?”
In this episode, we discuss the effect of the COVID-19 pandemic on the health of rheumatologists and how this may have an impact on delivering patient care.
Meghna Rao is a postgraduate in the biological sciences from the University of Leeds, United Kingdom, where she also completed a thesis in enzyme kinetics using electrochemical methods. Meghna was a part of the research team at a biopharmaceutical company in India, after which she transitioned into scientific and medical communications and publishing.
In her 10 years of experience as a scientific and medical communicator, Meghna has explored content creation and development on diverse platforms, working with various different organizations in the fields of science, medicine, and health, for audiences both clinical and nonclinical.
Meghna is currently the medical editor of Rheumatology Advisor, the host of the medical podcast, Rheum Advisor on Air, and a freelance writer.
Stephan Cho, is the Digital Content Editor for Cancer Therapy Advisor and the editor of the Rheum Advisor on Air podcast.
